--- Chain 1 for Question 158 ---
Status: PRUNED
Is Active Flag: False
Finish Reason: worker_terminated_unexpectedly
Reasoning Complete Flag: True
Error: None
Prompt Tokens: 210
Completion Tokens: 506
Completed Thoughts: 2
Accumulated Pruned Count: 0
Pruned at Analysis Step: 4
Pruned By Chain ID: q158_c2
Final Processed Boundaries: [0, 779]

--- Full Content ---
Okay, so I've got this question about transcription factors and mutations. Hmm, let's try to break it down. I'm a bit rusty, but I'll think through it step by step.

So, the question says that a transcription factor has an inactive state, and it's waiting for a signal from a membrane phosphorylation cascade. When it gets phosphorylated on the serine residues in the transactivation domain, it dimerizes, moves into the nucleus, and helps with gene transcription.

There are two mutations mentioned: missense mutation X in the transactivation domain, which is a recessive loss-of-function. Then there's mutation Y in the dimerization domain, which is a dominant-negative mutation and it's heterozygous. The question is about the molecular phenotype when mutation Y is present.

Wait, dominant-negative mutations usually interfere with the function of the protein, even when present in one copy. How does that happen? I think dominant-negative mutations often prevent the normal allele from functioning. Like, if the mutant protein can't do something, it might interfere with the wild-type version.

So the wild-type protein would have the dimerization domain working. Without mutation Y, when the protein is phosphorylated, it dimerizes, goes into the nucleus, and works. But with mutation Y, which is in the dimerization domain, maybe the mutant subunit can't form dimers correctly.

Wait, but since Y is a dominant-negative, the mutant allele's protein product (let's say it's a subunit) might form a non-functional complex with the wild-type subunit. So if a transcription factor is a dimer, each subunit needs to be functional. Suppose each subunit is a monomer that when phosphorylated dimerizes. If one subunit is mutant Y, which can't dimerize properly, it might prevent the other from forming a proper dimer.

So in a heterozygous case, the cell has some mutant and some wild-type subunits. The mutant Y might form a dimer with wild-type, but since the dimerization is faulty, the whole complex can't function. So even if the wild-type is present, the presence of the mutant would prevent the proper dimer formation.

Looking at the options, which one fits this scenario.

Option A: Change of protein conformation and gain-of-function. I don't think so. Dominant-negative usually leads to loss of function, not gain.

Option B: Protein